期刊文献+

^(18)F及其PET显像剂 被引量:2

Fluorine-18 nuclide and its PET imaging agent
下载PDF
导出
摘要 18F具有优越的物理特性,相对长的半衰期允许有较充足的药物标记和显像研究时间,其类氢特性不至于引起标记分子的空间结构发生明显改变,因此,18F广泛用于标记葡萄糖、氨基酸、脂肪酸、核苷、受体的配体和神经递质等分子,利用PET探查血流、代谢、蛋白质合成和神经递质功能活动,借以诊断肿瘤、心脏疾病、神经和精神性疾病,并指导和确定疾病的治疗方案。因此,掌握并了解18F及其标记化合物的生产合成,将对生物功能影像学和分子核医学的发展具有非常重要的意义。 Fluorine-18has predominant physical features with long half-life and the enough time for preparation of ra-diopharmaceuticals and PET imaging.Also,the chemical nature of fluorine-18is similar to that of hydrogen,and the flu-orine-18labelled organic molecules can't change the non-labelled molecular character.Therefore,fluorine-18is widely applied in the labelled glucose,amino acids,fatty acids,nucleotide,receptor-ligand and neurotransmitter molecular etc.,with the propose of detecting the blood flow,metabolism,synthesis of the protein and the neurotransmitter function in brain by PET imaging.It is very important in the basic science and clinical research to understand and master the prepa-ration of the fluorine-18and its labelled compounds.
作者 王明芳
机构地区 第一军医大学
出处 《国外医学(放射医学核医学分册)》 2003年第1期17-20,共4页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 氟-18 正电子显像剂 制备 应用 fluorine-18nuclide PET imaging agent preparation application
  • 相关文献

参考文献1

二级参考文献14

  • 1Saha GB,MacIntyre WJ,Go RT.Radiopharmaceuticals for brain imaging [J].Semin Nucl Med,1994,24(4) :324-349.
  • 2Beason-Held LL,Desmond RE,Herscovitch P,et al.Bolus injection versus slow infusion of [15O]water for positron emission tomography activation studies [J].J Cereb Blood Flow Metab,1999,19(8): 843-852.
  • 3Herscovitch P,Raichle ME,Xilbourn MR,et al.Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol [J].JCereb Blood Flow Metab,1987,7:527-542.
  • 4Herholz K,Holzer T,Schroder R,et al.11C-methionine PET for differential diagnosis of low-grade gliomas [J].Neurology,1998,50(5):1316-1322.
  • 5Kaschten B,Stevenaert A,Sadzot B,et al.DeprezM ;Preoperative evaluation of 54 gliomas by PET with fluorine- 18-fluorodeoxyglucose and/or carbon- 11-methionine [J].J Nucl Med,1998,39(5): 778-785.
  • 6Coleman RE,Hoffman JM,Hanson MW et al.Clinical application of PET for the evaluation of brain tumors [J].JNuclMed,1991,32: 616-622.
  • 7Mineura K,Sasajima T,Kowada M,et al.Indications for differential diagnosis of nontumor central nervous system diseases from tumors.A positron emission tomography study [J].J Neuroimag,1997,7(1) :8-15.
  • 8Cohen RM,Carson RE,Aigner TG,et al.Opiate receptor avidity is reduced in on-motor impaired MPTPlesioned rhesus monkeys [J].Brain Res,1998,806(2):292-296.
  • 9Wagner HN.A brief history of positron emission tomography (PET) [J].Semin Nucl Med,1998,28(3):213-220.
  • 10Meltzer CC,Zubieta JK,Links JM,et al.MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution [J].J Cereb Blood Flow Metab,1996,16 (4): 650-658.

共引文献6

同被引文献33

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部